Esophageal Cancer Genetics Studies | MicrobiomeTrials← Back to trialsNCT00341276
Esophageal Cancer Genetics Studies
CompletedOBSERVATIONAL
Trial Details
Start: 1995-07-06Est. Completion: 2020-03-18
Enrollment target: 7,705 participants Locations- Shanxi Tumor Hospital and Institute, Taiyuan, China
- Yangcheng County Cancer Hospital and Institute, Yangcheng, China
Other microbiome trials you might be interested in
Advanced Esophageal Squamous Cell CarcinomaMetastatic Esophageal Squamous Cell Carcinoma
The purpose of this study is to evaluate the pharmacokinetic (PK) profile, safety, and efficacy of tislelizumab administ…
Multiple LocationsEst. completion Feb 28, 2028
Advanced Esophageal AdenocarcinomaAdvanced Gastric AdenocarcinomaAdvanced Gastroesophageal Junction AdenocarcinomaClinical Stage II Esophageal Adenocarcinoma AJCC v8Clinical Stage III Esophageal Adenocarcinoma AJCC v8Clinical Stage III Gastric Cancer AJCC v8Clinical Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8Clinical Stage IV Esophageal Adenocarcinoma AJCC v8Clinical Stage IV Gastric Cancer AJCC v8Clinical Stage IV Gastroesophageal Junction Adenocarcinoma AJCC v8Metastatic Esophageal AdenocarcinomaMetastatic Gastric AdenocarcinomaMetastatic Gastroesophageal Junction AdenocarcinomaUnresectable Esophageal AdenocarcinomaUnresectable Gastric AdenocarcinomaUnresectable Gastroesophageal Junction Adenocarcinoma
This phase II/III trial compares the addition of nivolumab to the usual treatment of paclitaxel and ramucirumab to pacli…
Little Rock, United StatesEst. completion Oct 31, 2027